YD Bio Limited (YDES)
NGM · Healthcare · Biotechnology
$2.97
-1.33%
Closing price as of 2026-06-08 · Source: TEK2day Finance
Key Metrics
Market Cap
$282.6M
Exchange
NGM
About YD Bio Limited
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Revenue | 350K | 510K | 597K |
| Gross Profit | 153K | 155K | 167K |
| Operating Income | -7K | -1.5M | -5.3M |
| Net Income | 14K | -1.4M | -8.3M |
| Diluted EPS | $0.00 | $nan | $nan |